Heron Therapeutics Inc (HRTX) returns
Heron Therapeutics returns over 10 years
$1,000 invested in Heron Therapeutics ten years ago was worth $18.33 at the close on October 30, 2026, with dividends reinvested: an average return of -33.0% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -11.4% | — | $885.81 | -0.9% |
| 3 months | -44.2% | — | $558.30 | +2.1% |
| Year to date | -78.6% | — | $213.62 | +11.7% |
| 1 year | -75.6% | — | $243.60 | +12.4% |
| 3 years | -55.9% | -23.9% | $440.79 | +88.5% |
| 5 years | -97.5% | -52.1% | $25.22 | +76.0% |
| 10 years | -98.2% | -33.0% | $18.33 | +316.6% |
Heron Therapeutics return by calendar year
| Year | HRTX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -78.6% | +11.7% | -90.3% |
| 2025 | -15.0% | +17.7% | -32.7% |
| 2024 | -10.0% | +24.9% | -34.9% |
| 2023 | -32.0% | +26.2% | -58.2% |
| 2022 | -72.6% | -18.2% | -54.4% |
| 2021 | -56.9% | +28.7% | -85.6% |
| 2020 | -9.9% | +18.4% | -28.3% |
| 2019 | -9.4% | +31.2% | -40.6% |
| 2018 | +43.3% | -4.6% | +47.9% |
| 2017 | +38.2% | +21.7% | +16.5% |
| 2016 | -50.9% | +12.0% | -62.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: HRTX financials
No forecast, no recommendation. This page describes Heron Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.